Healthcare -
Medical - Healthcare Information Services - NYSE - US
$ 238.32
-1.76 %
$ 38.8 B
Market Cap
54.02
P/E
1. INTRINSIC VALUE
Balance Sheet
Veeva Systems Inc.
| Current Assets | 6.31 B |
| Cash & Short-Term Investments | 5.15 B |
| Receivables | 1.06 B |
| Other Current Assets | 101 M |
| Non-Current Assets | 1.03 B |
| Long-Term Investments | 0 |
| PP&E | 120 M |
| Other Non-Current Assets | 911 M |
| Current Liabilities | 1.4 B |
| Accounts Payable | 30.4 M |
| Short-Term Debt | 9.97 M |
| Other Current Liabilities | 1.36 B |
| Non-Current Liabilities | 109 M |
| Long-Term Debt | 0 |
| Other Non-Current Liabilities | 109 M |
EFFICIENCY
Earnings Waterfall
Veeva Systems Inc.
| Revenue | 2.75 B |
| Cost Of Revenue | 700 M |
| Gross Profit | 2.05 B |
| Operating Expenses | 1.36 B |
| Operating Income | 691 M |
| Other Expenses | -22.7 M |
| Net Income | 714 M |
RATIOS
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Veeva Systems Inc.
| Net Income | 714 M |
| Depreciation & Amortization | 50.9 M |
| Capital Expenditures | 0 |
| Stock-Based Compensation | 437 M |
| Change in Working Capital | 7.62 M |
| Others | -94 K |
| Free Cash Flow | 1.09 B |
Wall Street Analysts Price Targets
Veeva Systems Inc.
Wall Street analysts predict an average 1-year price target for VEEV of $238 , with forecasts ranging from
a
low of
$197 to a high of $285 .
VEEV Lowest Price Target
Wall Street Target
197 USD
-17.34%
VEEV Average Price Target
Wall Street Target
238 USD
-0.28%
VEEV Highest Price Target
Wall Street Target
285 USD
19.59%
4. DIVIDEND
ANALYSIS
VEEV does not distribute dividends.
5. COMPETITION
6. Ownership
Insider Ownership
Veeva Systems Inc.
Sold
0-3 MONTHS
1.48 M USD 3
3-6 MONTHS
390 K USD 1
6-9 MONTHS
741 K USD 2
9-12 MONTHS
2.76 M USD 1
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
Veeva to Release Fiscal 2026 First Quarter Results on May 28, 2025
PLEASANTON, Calif. , May 7, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) will announce financial results for its first quarter, which ended April 30, 2025, after market close on May 28, 2025.
prnewswire.com
- 1 week ago
Life Sciences Leaders Advance Unified Engagement at Veeva Commercial Summit
AstraZeneca, Bayer, Boehringer Ingelheim, Eli Lilly and Company, and more share strategies for more connected customer experiences across sales, marketing, and medical PLEASANTON, Calif. , May 6, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced its keynote speakers for the 2025 Veeva Commercial Summit, May 13-14 in Boston.
prnewswire.com
- 1 week ago
Veeva: Our 2025 Software Pick Just Keeps Winning
I believe Veeva's robust product roadmap, including the introduction of Veeva AI, should deepen adoption and drive productivity across its Development and Commercial Cloud segments. Despite a projected revenue growth slowdown in FY26, Veeva's management remains confident in achieving its $6B revenue target by 2030. VEEV's strong financial discipline is evident, with non-GAAP operating margins expected to expand to 43% in FY26 despite a projected revenue slowdown.
seekingalpha.com
- 1 week ago
Life Science Analytics Market worth $68.81 billion by 2030 11.4% CAGR | MarketsandMarkets™
DELRAY BEACH, Fla., May 2, 2025 /PRNewswire/ -- The global Life Science Analytics Market , valued at US$35.69 billion in 2024, is forecasted to grow at a robust CAGR of 11.4%, reaching US$40.03 billion in 2025 and an impressive US$68.81 billion by 2030. The standardization of diverse datasets from sources such as clinical trials, electronic health records (EHRs), genomics, and real-world evidence is essential for the efficient exchange of information across various platforms and geographical regions. This standardization enhances multi-site clinical trials and cross-border research collaborations. Additionally, emerging technologies like artificial intelligence (AI), quantum computing, and cognitive computing play a vital role in transforming large volumes of raw data into actionable insights. These technologies help simplify reports and create interactive dashboards. Furthermore, the increasing adoption of analytics in pre-clinical trials, drug discovery, and clinical trials, particularly for applications such as patient recruitment and site identification, helps to reduce the workload for researchers and investigators. These factors contribute significantly to the growing adoption of analytics across the life sciences industry. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174990653 Browse in-depth TOC on "Life Science Analytics Market" 100 - Tables50 - Figures500 - Pages By Based on type, the life science analytics services market is categorized into two main types: managed services and professional services. In 2024, the managed services segment held the largest share of the life science analytics market. This significant share is largely due to the increasing demand for advanced insights, the need for cost-effective drug development, technological advancements in the industry, and the necessity for ongoing support in strategic decision-making. These factors make outsourcing analytics and consulting more attractive for life science companies. Leading companies in the field offer consulting services that leverage data and analytics to evaluate opportunities, design analytics strategies, and implement appropriate technology solutions. For instance, in May 2023, SAS Institute (US) partnered with HTEC (US) to deliver strategic analytics consulting services across various sectors, including life sciences and healthcare. By Based on applications, The life science analytics market is divided into several applications, including research & development, commercial analytics, regulatory compliance, manufacturing and supply chain optimization, and safety. In 2024, the research & development segment held the largest share of this market. This significant share is mainly due to its capacity to accelerate drug discovery, optimize clinical trials, and improve research accuracy through advanced data analysis and AI-driven insights. Additionally, factors such as increasing R&D expenditure in the pharmaceutical and biopharmaceutical sectors, a rise in patent expirations and declining drug pipelines, and a growing focus on personalized medicine and precision therapeutics are further driving growth in this segment. By geography, the life science analytics market is divided into five primary regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The Asia Pacific region is expected to experience significant growth, with a noticeable annual growth rate during the forecast period. Key factors driving the expansion of life science analytics solutions in this region include a gradual shift towards adopting advanced technologies such as automation, artificial intelligence (AI), and machine learning (ML). Additionally, rising investments are attracting new market players, and the presence of leading educational institutions and research centers in Asia Pacific is fostering scientific innovation and technological advancement. Furthermore, increased direct investments from pharmaceutical and biotechnology companies in Europe and North America are anticipated to boost the adoption of life science analytics solutions in Asia. Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=174990653 Oracle (US), Merative (formerly IBM) (US), SAS Institute (US), Accenture (Ireland), IQVIA (US), Cognizant (US), Wipro (India), Veradigm (US), Optum (US), Microsoft (US), MaxisIT (US), ExlService Holdings (US), Inovalon (US), CitiusTech (US), Saama (US), Axtria (US), Clarivate (UK), ThoughtSphere (US), ThoughtSpot (US), Salesforce (US), Google LLC (US), Amazon Web Services, Inc. (US), Veeva Systems (US), Elsevier (Netherlands), and Komodo Health, Inc. (US) are the major players in this market. These companies mainly focus on strategies such as acquisitions, collaborations, partnerships, expansion, and product launches and updates to remain competitive and further increase their share in the market. ORACLE (US): Oracle (US) is a leading company in life science analytics worldwide. The company offers analytics software and services for various applications, including research & development, commercialization, and more. Oracle is committed to continuously updating its products to meet customer expectations. Additionally, the company invests in expanding its solutions through partnerships and collaborations, ensuring tailored solutions for its users. In March 2025, Oracle partnered with Huntsville Hospital Health System (US) to standardize its Oracle Health Foundation electronic health record system across all facilities. This collaboration aims to provide consistent, high-quality care and a unified experience for both patients and providers as they move between different locations. With a broad customer base and a significant geographic presence, Oracle is a critical player in various IT software, hardware, and service markets, including life science analytics. MERATIVE (US): Merative (US) is another leading player in the life science analytics market. The company offers a comprehensive suite of informatics products and services tailored for life science analytics. By leveraging advanced technologies such as AI and ML, Merative enhances the accuracy and efficiency of evidence analysis. Its strong brand recognition and extensive product portfolio have significantly contributed to its success. Merative serves various sectors, including life science systems, clinical trial sponsors, and the medical device manufacturing industry. Additionally, the company has established offices across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. SAS INSTITUTE INC. (US) SAS Institute Inc. (US) is a company that specializes in analytics software and services. It offers a wide range of solutions, including advanced analytics, business intelligence, cloud analytics, customer intelligence, data operations, data management, decision management, fraud and security intelligence, in-memory analytics, performance management, risk management, and supply chain management. These solutions enable organizations to access, manage, analyze, and report on data to support informed decision-making. SAS Institute serves various industries, including communications, education, financial services, government, health insurance, healthcare, hospitality, insurance, life sciences, manufacturing, media, oil and gas, retail, travel and transportation, and utilities. Through its Life Sciences industry segment, the company also provides specialized analytics solutions for the life sciences sector. By leveraging AI and analytics driven by fast and relevant data, SAS aims to propel innovation in health and life sciences. The company supports customers in 146 countries across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. More than 82,000 business, government, and university sites utilize SAS OnDemand for Academics. For more information, Inquire Now! Related Reports: Healthcare Analytics Market Healthcare BPO Market Healthcare IT Market Artificial Intelligence (AI) in Healthcare Market Healthcare Data Monetization Market Get access to the latest updates on Life Science Analytics Companies and Life Science Analytics Market Size About MarketsandMarkets™ MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress Ave.Suite 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: [email protected]Visit Our Website: https://www.marketsandmarkets.com/ Logo: https://mma.prnewswire.com/media/1868219/MarketsandMarkets_Logo.jpg
https://www.prnewswire.com
- 2 weeks ago
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Veeva Systems (VEEV) closed the most recent trading day at $232.07, moving -0.69% from the previous trading session.
zacks.com
- 2 weeks ago
Investors Heavily Search Veeva Systems Inc. (VEEV): Here is What You Need to Know
Veeva (VEEV) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
zacks.com
- 2 weeks ago
Announcing Veeva AI
Major new initiative will add AI to Veeva applications and the Veeva Vault Platform to help automate critical industry-specific functions and improve productivity from clinical to commercial PLEASANTON, Calif. , April 29, 2025 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced Veeva AI, a major new initiative that adds AI to the Veeva Vault Platform and Veeva applications to help life sciences companies automate tasks and improve employee productivity using AI Agents and AI Shortcuts.
prnewswire.com
- 2 weeks ago
Veeva Systems (VEEV) Stock Declines While Market Improves: Some Information for Investors
Veeva Systems (VEEV) closed the most recent trading day at $227.11, moving -0.26% from the previous trading session.
zacks.com
- 3 weeks ago
Here's Why You Should Add Veeva Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
zacks.com
- 3 weeks ago
3 Medical Info Systems Stocks to Ride the AI Wave in Trump Tariff Era
Zacks Medical Info Systems industry stocks like VEEV, HIMS and BFLY are expected to gain from the Stargate Project and provide relief amid tariff tension.
zacks.com
- 4 weeks ago
Wall Street Bulls Look Optimistic About Veeva (VEEV): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
zacks.com
- 1 month ago
Don't Try to Time the Market: These 2 Stocks Are Buys Regardless of What Happens Next
Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs on imported goods from most countries for 90 days.
fool.com
- 1 month ago
8. Profile
Summary
Veeva Systems Inc. VEEV
COUNTRY
US
INDUSTRY
Medical - Healthcare Information Services
MARKET CAP
$ 38.8 B
Dividend Yield
0.00%
Description
Veeva Systems Inc. provides cloud-based software for the life sciences industry in North America, Europe, the Asia Pacific, the Middle East, Africa, and Latin America. The company offers Veeva Commercial Cloud, a suite of software, data, and analytics solutions, which include Veeva customer relationship management (CRM) and Veeva Medical CRM, Veeva CLM, Veeva CRM MyInsights, Veeva CLM, Veeva CRM Approved Email, Veeva CRM Engage, Veeva Align, Veeva CRM Events Management, Veeva Nitro, Veeva OpenData, Veeva Link, Veeva Network, Veeva Crossix, Veeva Data Cloud, and MyVeeva for Patients; and Veeva Vault, a cloud-based enterprise content and data management applications for managing commercial functions, including sales and marketing, and medical content and communications, as well as research and development functions, such as clinical, regulatory, quality, and safety. It also provides professional and support services in the areas of implementation and deployment planning and project management; requirements analysis, solution design, and configuration; systems environment management and deployment services; services focused on advancing or transforming business and operating processes related to Veeva solutions; technical consulting services related to data migration and systems integrations; training on its solutions; and ongoing managed services that include outsourced systems administration. The company was formerly known as Verticals onDemand, Inc. and changed its name to Veeva Systems Inc. in April 2009. Veeva Systems Inc. was incorporated in 2007 and is headquartered in Pleasanton, California.
Contact
4280 Hacienda Drive, Pleasanton, CA, 94588
https://www.veeva.com
IPO
Date
Oct. 16, 2013
Employees
7291
Officers
Ms. Kristine B. Diamond
Principal Accounting Officer
Mr. Gunnar Georg Hansen
Director of Investor Relations
Mr. Thomas D. Schwenger
President & Chief Customer Officer
Mr. Pinal Patel
Chief Information Officer
Mr. Jacques Mourrain Ph.D.
Vice President of Quality, Regulatory & Compliance
Ms. Vivian Welsh
Chief People Officer
Ms. Eleni Nitsa Zuppas
President & Chief of Staff
Mr. Brian Van Wagener
Chief Financial Officer
Mr. Jonathan W. Faddis J.D.
Senior Vice President, General Counsel & Corporate Secretary
Mr. Peter P. Gassner
Founder, Chief Executive Officer & Director